Research News and Research

RSS

Today's Opinions: Broken promises, Boehner's Plan B and implementing reform

My sister's cancer sent me into the medical literature with an insatiable hunger for information. It's this search for answers and 20 years of experience caring for women many of whom bore physical or emotional scars acquired in the aftermath of suspicious or inconclusive mammograms that led me to decide that I could no longer endorse the tests as routine screening measures for me or any other woman

13 Oct 2010

Vaccine lawsuits – Justices divided

The US Supreme Court is seemingly divided over the lawsuits on childhood vaccines. The Justices acquiesced that the Congress has done its bit to shield vaccine-makers from suits by the few who have had an adverse reaction to a vaccine approved by the Food and Drug Administration. Now the matter revolves around whether those hurt by vaccines have the right to sue manufacturers if they can prove that a safer version was available.

12 Oct 2010

Nutrition for the aged

Experts believe nutrition in the aged needs to be a priority. They say that it should be ensured that the aged get access to good, nutritious food during the winter months.

12 Oct 2010

Australian women stressed and overweight: Survey

In a poll known as “Australia's Biggest Health Check” 26,000 responders showed that Australia's women feel stressed out and unfit and overworked. It also shows that they have barely half an hour of leisure time per day and the mismatch between how much sex women want versus what they get. The survey was promoted via two magazines - Women's Health and Prevention - and also had the backing of Priceline and the Seven Network’s Sunrise program. There were 24,500 women and 1,500 men in on the poll.

12 Oct 2010

Elsevier, AMP, ASIP to publish The Journal of Molecular Diagnostics

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).

12 Oct 2010

Elsevier, ASIP to publish The American Journal of Pathology

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The American Journal of Pathology (AJP) in partnership with the American Society for Investigative Pathology (ASIP).

12 Oct 2010

PlastiPure awarded NIH and NSF grants to develop EA-Free material and products

PlastiPure, a safe plastics technology company, announced today that it has received two grants from the National Institute of Environmental Health and Safety (NIEHS), a division of the NIH, and an additional grant from the National Science Foundation (NSF). Collectively the grants fund formulation of a replacement for polycarbonate that is free of estrogenic activity (EA-Free), creating flexible food packaging that contains no EA, and developing a verifiably EA-Free baby bottle.

12 Oct 2010

Smart for Life(R) to add Lepticore(R) to product line

Smart for Life(R), the trailblazing company featuring weight management products will begin adding Lepticore(R) to its product line this month.

12 Oct 2010

Rad51 protein plays a key role in DNA protection

Cancer Research UK scientists have shed new light on the vital role that a protein plays in protecting our DNA, reveals a study published in Nature Structural and Molecular Biology today.

12 Oct 2010

OICR announces equity investment in Privacy Analytics

The Ontario Institute for Cancer Research (OICR) today announced it has made an equity investment in Privacy Analytics Inc., an Ontario company that is developing a software platform to help organizations such as health centers disclose detailed disease and treatment data without compromising individual privacy.

12 Oct 2010

USPTO issues Watson Notice of Allowance for key progesterone patent to treat or prevent preterm birth

Columbia Laboratories, Inc. announced today that the U.S. Patent and Trademark Office (USPTO) has issued Watson Pharmaceuticals, Inc. a Notice of Allowance for a key patent for the use of progesterone to treat or prevent preterm birth. The USPTO issues a Notice of Allowance to report that a patent application has been examined and is allowed for issuance as a patent. The patent is expected to issue within three months upon payment of required fees.

12 Oct 2010

ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer

ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.

12 Oct 2010

Mobile outreach program by sex workers provides key link to health, support services

A mobile outreach program staffed by current and former sex workers is associated with increased entry to detoxification and residential drug treatment among women in street-based sex work, according to an evaluation led by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia (UBC).

12 Oct 2010

Cincinnati Children's, Nationwide Children's Hospital collaborate to improve ADHD care

Doctors at Cincinnati Children's Hospital Medical Center and Nationwide Children's Hospital are collaborating to help pediatricians deliver better care to children with ADHD.

12 Oct 2010

VNSNY adopts advanced information technology to improve patient care

Unlike most home healthcare agencies, which have restricted the use of computer programs to such non-patient-care items as billing, the Visiting Nurse Service of New York has adopted advanced information technology in order to improve patient care. One of the results, documented in a new publication, is a significant 10% reduction in patient episodes ending in hospitalization, from 37% to 27% over the years 2001-2009.

12 Oct 2010

Alimera to present Iluvien Phase 3 clinical trial data at AAO annual meeting

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from its Phase 3 (FAME) clinical trials for Iluvien will be presented this month at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.

12 Oct 2010

NCKU develops novel stem cell therapy for heart repair

Assistant Prof. Patrick C. H. Hsieh of Institute of Nanotechnology and Microsystems Engineering, College of Medicine, National Cheng Kung University (NCKU), Tainan, Taiwan, has led a research team of myocardial regeneration to conduct an experiment on pigs and has proved that by combining self-assembling peptide nanofiber hydrogel with autologous bone marrow stem cell, myocardial protection after acute myocardial infarction, vascular regeneration and heart functions can be improved.

12 Oct 2010

Engaging in healthy lifestyle can help women with family history control breast cancer risk

Having a family history of breast cancer can lead some women to wonder if the risk is out of their control. However, a study of more than 85,000 postmenopausal women, published in BioMed Central's open access journal Breast Cancer Research, observed that regular physical activity, maintaining a healthy weight, and drinking less alcohol lowers breast cancer risk for those with and without a family history of the disease.

12 Oct 2010

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Adeona Pharmaceuticals, Inc., announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline.

12 Oct 2010

Parents rate research on safety of vaccines and medications given to children as most important

Each year, hundreds of millions of public and private dollars are spent on medical research to improve the health of children – yet parents have little input regarding how those dollars should be spent.

12 Oct 2010

Research News and Research

Today's Opinions: Broken promises, Boehner's Plan B and implementing reform

Vaccine lawsuits – Justices divided

Nutrition for the aged

Australian women stressed and overweight: Survey

Elsevier, AMP, ASIP to publish The Journal of Molecular Diagnostics

Elsevier, ASIP to publish The American Journal of Pathology

PlastiPure awarded NIH and NSF grants to develop EA-Free material and products

Smart for Life(R) to add Lepticore(R) to product line

Rad51 protein plays a key role in DNA protection

OICR announces equity investment in Privacy Analytics

USPTO issues Watson Notice of Allowance for key progesterone patent to treat or prevent preterm birth

ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer

Mobile outreach program by sex workers provides key link to health, support services

Cincinnati Children's, Nationwide Children's Hospital collaborate to improve ADHD care

VNSNY adopts advanced information technology to improve patient care

Alimera to present Iluvien Phase 3 clinical trial data at AAO annual meeting

NCKU develops novel stem cell therapy for heart repair

Engaging in healthy lifestyle can help women with family history control breast cancer risk

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Parents rate research on safety of vaccines and medications given to children as most important

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News